Theravance Biopharma (TBPH) Asset Writedowns and Impairment (2015 - 2024)
Theravance Biopharma's (TBPH) quarterly Asset Writedowns and Impairment came in at $1.6 million in Q3 2024, up 1510.31% on a QoQ basis from $97000.0 in Q4 2017.
Theravance Biopharma (TBPH) Asset Writedowns and Impairment (2015 - 2024) Analysis & Trends
Theravance Biopharma (TBPH) has 4 years of Asset Writedowns and Impairment data on file, last reported at $1.6 million in Q3 2024.
- On a quarterly basis, Asset Writedowns and Impairment changed N/A year-over-year to $1.6 million in Q3 2024; TTM through Dec 2024 was $9.7 million, a N/A change from a year earlier, with the FY2024 full-year figure at $4.5 million, changed N/A from the prior year.
- Asset Writedowns and Impairment for Q3 2024 stood at $1.6 million, up from $97000.0 in the prior quarter.
- Over the last five years, Asset Writedowns and Impairment for TBPH reached as high as $1.6 million in Q3 2024 and fell as low as $1.6 million in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Theravance Biopharma | 864.56 Mn | 469.90 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | 1.56 Mn |
| Sep 30, 2024 | 1.56 Mn |
| Dec 31, 2017 | 97,000.00 |
| Dec 31, 2017 | 97,000.00 |
| Sep 30, 2017 | 8.00 Mn |
| Sep 30, 2017 | 8.00 Mn |
| Jun 30, 2017 | 642,000.00 |
| Jun 30, 2017 | 642,000.00 |
| Dec 31, 2016 | 184,000.00 |
| Dec 31, 2016 | 184,000.00 |
| Jun 30, 2016 | 109,000.00 |
| Jun 30, 2016 | 109,000.00 |
| Mar 31, 2016 | 10,000.00 |
| Mar 31, 2016 | 10,000.00 |
| Dec 31, 2015 | -79,000.00 |
| Dec 31, 2015 | -79,000.00 |
| Mar 31, 2015 | 79,000.00 |
| Mar 31, 2015 | 79,000.00 |